Eli Lilly & Co. (LLY) Falls as Bernie Sanders Questions Insulin Drug Price Increases

November 1, 2016 12:50 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Eli Lilly & Co. (NYSE: LLY) is lower after Bernie Sanders highlighted the surging cost of the company's insulin drug Humalog. Shares are down 1.8%.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment